Biotech News
Related news
IRIXIRIDEX2026-10-05 11:00 EST
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
IRIXIRIDEX2026-08-18 20:05 EST
Iridex Reports Second Quarter 2026 Financial Results
ANGOAngioDynamics2026-10-21 12:30 EST
AngioDynamics Announces Publication of DIRECT Study Results and New Category I CPT Code for Pancreatic IRE
ANGOAngioDynamics2026-10-14 11:00 EST
AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife® IRE for Prostate and Liver Cancer
PLSEPulse Biosciences2026-10-08 11:00 EST
Pulse Biosciences’ nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026
SGHTSight Sciences2026-10-01 11:05 EST
Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting
DCTHDelcath Systems2026-10-19 20:01 EST
Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma
HYPRHyperfine2026-09-28 12:15 EST
Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets
IARTIntegra LifeSciences2026-09-25 13:05 EST
Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026
HYPRHyperfine2026-08-26 12:15 EST
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
IRIDEX
Ophthalmic Laser Technology Company Iridex develops, manufactures, and markets laser-based medical systems, delivery devices, and accessories for ophthalmology. Its products are used by eye-care specialists to treat glaucoma, diabetic macular edema, and other retinal diseases. MicroPulse Technology The company's proprietary MicroPulse...
Recent company news
IRIXIRIDEX2026-10-12 11:00 EST
Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced Glaucoma
IRIXIRIDEX2026-10-05 11:00 EST
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
IRIXIRIDEX2026-08-18 20:05 EST
Iridex Reports Second Quarter 2026 Financial Results
IRIXIRIDEX2026-08-04 20:05 EST
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
IRIXIRIDEX2026-07-20 11:00 EST
Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
Stock data
- Close
- 0.77 USD
- Market cap
- 20.37M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States